TRPV1 (vanilloid receptor, capsaicin receptor) agonists and antagonists

被引:25
作者
Appendino, G
Muñoz, E
Fiebich, BL
机构
[1] Dipartimento Sci Chim Alimentari Farmaceut & Farm, I-10131 Novara, Italy
[2] Univ Cordoba, Dept Biol Celular Fisiol & Immunol, E-14004 Cordoba, Spain
[3] Vivacell Biotechnol GmbH, D-79211 Denzlingen, Germany
关键词
analgesics; capsaicin; chronic pain; transient receptor potential (TRP) channels; TRPV1; vanilloid receptors;
D O I
10.1517/eotp.13.12.1825.22908
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The vanilloid receptors (TRPVs) are a family of cation channels expressed both in neural and non-neural cells, which act as sensors for a variety of physical (heat, osmolarity) and ionic (increase of acidity, depletion of calcium stores) stimuli. As a druggable integrator of noxious signals and the target of the hot dietary alkaloid capsaicin, TRPV1 (vanilloid receptor 1, capsaicin receptor) has so far overshadowed the other vanilloid receptors. Ligand gating of TRPV1 is provided by a heterogeneous group of compounds named vanilloids, of which two prototypes (N-acylphenolamines and homovanillates) have been extensively investigated. Inhibition of vanilloid activity underlies the therapeutic application of vanilloids in a variety of diseases, such as chronic pain, bladder disorders and cough, and can be achieved by desensitisation or by antagonism. Both strategies have been pursued, resulting in the discovery of some promising compounds which have entered clinical trials.
引用
收藏
页码:1825 / 1837
页数:13
相关论文
共 87 条
[1]  
ABBOT LABS, 2001, Patent No. 0134805
[2]   Halogenation of a capsaicin analogue leads to novel vanilloid TRPV1 receptor antagonists [J].
Appendino, G ;
Harrison, S ;
De Petrocellis, L ;
Daddario, N ;
Bianchi, F ;
Moriello, AS ;
Trevisani, M ;
Benvenuti, F ;
Geppetti, P ;
Di Marzo, V .
BRITISH JOURNAL OF PHARMACOLOGY, 2003, 139 (08) :1417-1424
[3]   N-acylvanillamides:: Development of an expeditious synthesis and discovery of new acyl templates for powerful activation of the vanilloid receptor [J].
Appendino, G ;
Minassi, A ;
Morello, AS ;
De Petrocellis, L ;
Di Marzo, V .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (17) :3739-3745
[4]  
BAKTHAVATCHALAM R, 2002, Patent No. 0208221
[5]  
BIOGLAN LABS LTD, 2000, Patent No. 0050025
[6]  
BIOGLAN LABS LTD, 2000, Patent No. 00454801
[7]   Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide [J].
Bisogno, T ;
Hanus, L ;
De Petrocellis, L ;
Tchilibon, S ;
Ponde, DE ;
Brandi, I ;
Moriello, AS ;
Davis, JB ;
Mechoulam, R ;
Di Marzo, V .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (04) :845-852
[8]  
BRISTOL MYERS SQUIBB, 2002, Patent No. 0244210
[9]   The capsaicin receptor: a heat-activated ion channel in the pain pathway [J].
Caterina, MJ ;
Schumacher, MA ;
Tominaga, M ;
Rosen, TA ;
Levine, JD ;
Julius, D .
NATURE, 1997, 389 (6653) :816-824
[10]   N-oleoyldopamine, a novel endogenous capsaicin-like lipid that produces hyperalgesia [J].
Chu, CJ ;
Huang, SM ;
De Petrocellis, L ;
Bisogno, T ;
Ewing, SA ;
Miller, JD ;
Zipkin, RE ;
Daddario, N ;
Appendino, G ;
Di Marzo, V ;
Walker, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (16) :13633-13639